awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33429898-4909DB42-6C87-40DE-9891-B58B1E24D125
Q33429898-4909DB42-6C87-40DE-9891-B58B1E24D125
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429898-4909DB42-6C87-40DE-9891-B58B1E24D125
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.
P2860
Q33429898-4909DB42-6C87-40DE-9891-B58B1E24D125
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33429898-4909DB42-6C87-40DE-9891-B58B1E24D125
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96a07e995543ed69d05976610a7673a70f87f0c8
P2860
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study.